---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-042369"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2023-05-23T23:59:59+00:00"
generated_at: "2026-06-14T17:26:52.720284+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Unicycive receives Nasdaq notice for failure to meet $35M market value requirement

## Summary
- Nasdaq notified Unicycive on May 17, 2023 that common stock MV fell below $35M for 30 consecutive business days.
- Company has 180 calendar days, until November 13, 2023, to regain compliance.
- If compliance not met by deadline, stock may be delisted; company can appeal to a Hearings Panel.
- Unicycive will monitor market value and evaluate options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001213900-23-042369
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2023-05-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390023042369/0001213900-23-042369-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390023042369/ea179021-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-042369
- JSON: https://secwatch.observer/filing/0001213900-23-042369.json
- Plain text: https://secwatch.observer/filing/0001213900-23-042369.txt

## Key facts
- Listing & Compliance Notices
  Unicycive Therapeutics, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: May 17, 2023, Unicycive Therapeutics, Inc. (the “Company”) received written notification (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the market value of the Company’s Common Stock (the “Common Stock”), had closed below the minimum $35 million requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “Minimum Market Value Requirement”). The Notice has no immediate effect on the listing or trading of the Common Stock on the Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/1766140/000121390023042369/0001213900-23-042369-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.